INTECH Investment Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

INTECH Investment Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$481K	Sell	28,339 -6,606	-19%	-$106K	﹤0.01%	1362
2026 Q1	$518K	Sell	34,945 -20,840	-37%	-$305K	0.01%	1322
2025 Q4	$890K	Sell	55,785 -627	-1%	-$8.89K	0.01%	1191
2025 Q3	$623K	Sell	56,412 -12,061	-18%	-$132K	0.01%	1459
2025 Q2	$580K	Sell	68,473 -12,712	-16%	-$102K	0.01%	1519
2025 Q1	$653K	Buy	81,185 +25,562	+46%	+$207K	0.01%	1465
2024 Q4	$499K	Buy	55,623 +19,905	+56%	+$162K	﹤0.01%	1565
2024 Q3	$262K	Buy	+35,718	New	+$221K	﹤0.01%	1591

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's AUPH Position: Q2 2026 in Review

INTECH Investment Management reduced its Aurinia Pharmaceuticals (AUPH) stake by 19% in Q2 2026, selling an estimated $106K and leaving 28,339 shares worth $481K. The position accounts for ﹤0.01% of the portfolio, ranked #1362.

INTECH Investment Management first reported a position in AUPH in Q3 2024 and has held it in 8 quarters since. The position peaked at $890K in Q4 2025. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

INTECH Investment Management held 28,339 shares of Aurinia Pharmaceuticals worth $481K as of Q2 2026.
INTECH Investment Management sold 6,606 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $106K.
Aurinia Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1362 holding.
INTECH Investment Management first reported a position in Aurinia Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Aurinia Pharmaceuticals position peaked at $890K in Q4 2025.
281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.